Association of Soy and Exclusive Breastfeeding With Central Precocious Puberty: A Case-Control Study

João Soares Felício1, Angélica Leite de Alcântara1, Luísa Corrêa Janaú1

  • 1Endocrinology Division, University Hospital João de Barros Barreto, Federal University of Pará, Belém, Brazil.

Insights

Exclusive breastfeeding (EBF) likely protects against central precocious puberty (CPP), while soy intake may increase the risk. Further research is needed to confirm these findings on early puberty development.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Health

Background:

  • Central precocious puberty (CPP) is a condition characterized by early onset of puberty.
  • Dietary factors, including soy consumption and breastfeeding practices, are being investigated for their potential roles in CPP development.

Purpose of the Study:

  • To evaluate the association between exclusive breastfeeding (EBF) and soy intake with the risk of central precocious puberty (CPP) in girls.

Main Methods:

  • A retrospective case-control study involving 161 girls, with 84 diagnosed with CPP (case group) and 77 without (control group).
  • Statistical analyses included logistic regression to assess the impact of EBF duration and soy intake on CPP risk.

Main Results:

  • Exclusive breastfeeding (EBF) for over 6 months was associated with a protective effect against CPP (OR: 0.5; 95% CI: 0.3-0.9).
  • Soy intake was significantly higher in the CPP group (OR: 3.8; 95% CI: 1.5-6) and positively correlated with CPP presence.
  • Logistic regression confirmed EBF reduced CPP likelihood [OR = 0.187 (CI = 0.055-0.635)], while soy intake increased risk [OR = 3.505 (CI = 1.688-7.279)].

Conclusions:

  • Soy consumption is associated with an increased risk of central precocious puberty.
  • Exclusive breastfeeding (EBF) appears to be a protective factor against CPP.
  • Prospective studies are recommended to further elucidate these associations.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
794
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
385
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
34.3K
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
45.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.0K